IKBKB-DT and lung adenocarcinoma: Moreover, while the initial identification of ALAL-1 was due to its frequent amplification in lung adenocarcinomas, the lncRNA is also overexpressed in squamous tumors (head and neck and lung), indicating that ALAL-1 also plays a prominent role in squamous cancer.